AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Australian Clinical Labs Ltd

2.800

-0.020-0.71%

Volume:176.42K

Turnover:495.29K

Market Cap:522.25M

PE:22.71

High:2.830

Open:2.830

Low:2.790

Close:2.820

52wk High:2.990

52wk Low:1.771

Shares:186.52M

Float Shares:186.52M

Volume Ratio:1.04

T/O Rate:0.09%

Dividend:0.13

Dividend Rate:4.64%

EPS(TTM):0.123

EPS(LYR):0.123

ROE:14.93%

ROA:7.45%

PB:3.49

PE(LYR):22.71

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Australian Clinical Labs Appoints Deloitte as Auditor

Australian Clinical Labs Limited-Change of Auditor

THOMSON REUTERS

Australia's Optiscan Rises After Imaging More than 80 Cases in ACL Study

Optiscan Imaging Says 84 Cases Imaged in Study Using Digital Pathology Imaging Device

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/ACL.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ACL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ACL.AU\",,,,,undefined,":{"symbol":"ACL.AU","market":"AU","secType":"STK","nameCN":"Australian Clinical Labs Ltd","latestPrice":2.8,"timestamp":1791436320000,"preClose":2.82,"halted":0,"volume":176419,"delay":0,"changeRate":-0.0070921985815602905,"nameEN":"Australian Clinical Labs Ltd","floatShares":186518985,"shares":186518985,"eps":0.123299,"marketStatus":"Not Yet Opened","change":-0.02,"latestTime":"10-08 16:12:00 AEDT","open":2.83,"high":2.83,"low":2.79,"amount":495287,"amplitude":0.014184,"askPrice":2.83,"askSize":350,"bidPrice":2.79,"bidSize":5000,"shortable":3,"etf":0,"ttmEps":0.123299,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1791500400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":2.82,"dividendRate":0.046429,"openAndCloseTimeList":[[1791414000000,1791435600000]],"volumeRatio":1.0427480658431587,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"ACL.AU","preClose":2.82,"auctionPrice":2.8,"auctionVolume":20814,"auction":3,"marketStatus":"盘后竞价","timestamp":1791436203501}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ACL.AU\",,,,,undefined,":{"symbol":"ACL.AU","floatShares":186518985,"roa":"7.45%","roe":"14.93%","lyrEps":0.123299,"volumeRatio":1.0427480658431587,"shares":186518985,"dividePrice":0.13,"high":2.83,"amplitude":0.014184,"preClose":2.82,"low":2.79,"week52Low":1.771,"pbRate":"3.49","psRate":"0.71","week52High":2.99,"institutionHeld":0,"latestPrice":2.8,"committee":0.869159,"eps":0.123299,"divideRate":0.046429,"volume":176419,"delay":0,"ttmEps":0.123299,"open":2.83,"prevYearClose":2.613,"prevWeekClose":2.79,"prevMonthClose":2.85,"prevQuarterClose":2.85,"fiveDayClose":2.76,"twentyDayClose":2.76,"sixtyDayClose":2.33,"dividendPayoutRate":1.0312947399923966,"dividendGrowthYears":2,"dividendGrowthRate":0.020000000000000018,"fiveYearAvgDividendRate":0.07185181500901408},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACL.AU\",params:#limit:5,,,undefined,":[{"date":"2026-09-02","symbol":"ACL.AU","amount":0.0925,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-09-03","defaultRemindTime":1788307200000,"name":"Australian Clinical Labs Ltd","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-23","payableDate":"2026-09-03","currency":"AUD","dateTimestamp":1788271200000,"payDate":"2026-09-23"},{"date":"2026-08-17","symbol":"ACL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1786924800000,"name":null,"time":"","dateTimestamp":1786888800000,"actualEps":null},{"date":"2026-03-12","symbol":"ACL.AU","amount":0.0375,"announcedDate":"2026-02-16","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-03-13","name":"Australian Clinical Labs Ltd","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-13","currency":"AUD","dateTimestamp":1773234000000,"payDate":"2026-03-31"},{"date":"2026-02-16","symbol":"ACL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771196400000,"name":null,"time":"","dateTimestamp":1771160400000,"actualEps":null},{"date":"2025-09-01","symbol":"ACL.AU","amount":0.09,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-09-02","defaultRemindTime":1756684800000,"name":"Australian Clinical Labs Ltd","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-23","payableDate":"2025-09-02","currency":"AUD","dateTimestamp":1756648800000,"payDate":"2025-09-23"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACL.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2022-08-23","recordDate":"2022-08-24","paymentDate":"2022-09-15","value":0.41,"currency":"AUD"},{"executeDate":"2023-03-27","recordDate":"2023-03-28","paymentDate":"2023-04-26","value":0.07,"currency":"AUD"},{"executeDate":"2023-09-14","recordDate":"2023-09-15","paymentDate":"2023-10-03","value":0.07,"currency":"AUD"},{"executeDate":"2024-03-28","recordDate":"2024-04-02","paymentDate":"2024-04-26","value":0.03,"currency":"AUD"},{"executeDate":"2024-09-04","recordDate":"2024-09-05","paymentDate":"2024-09-27","value":0.09,"currency":"AUD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ACL.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672848718","title":"Australian Clinical Labs Appoints Deloitte as Auditor","url":"https://stock-news.laohu8.com/highlight/detail?id=2672848718","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672848718?lang=en_us&edition=fundamental","pubTime":"2026-10-02 16:20","pubTimestamp":1790929220,"startTime":"0","endTime":"0","summary":"BRIEF-Australian Clinical Labs Appoints Deloitte As AuditorOct 2 (Reuters)-Australian Clinical Labs LimitedACL.AX:AUSTRALIAN CLINICAL LABS LIMITED-CHANGE OF AUDITORAUSTRALIAN CLINICAL LABS - APPOINTS DELOITTE AS AUDITOR EFFECTIVE 28 OCTOBER 2026 AFTER AGMFurther company coverage:ACL.AX","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nTUE9TV7QB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7124","ACL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672279428","title":"Australian Clinical Labs Limited-Change of Auditor","url":"https://stock-news.laohu8.com/highlight/detail?id=2672279428","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672279428?lang=en_us&edition=fundamental","pubTime":"2026-10-02 13:55","pubTimestamp":1790920500,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261002:nTUE9TV7QB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ACL.AU","BK7124"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666559449","title":"Australia's Optiscan Rises After Imaging More than 80 Cases in ACL Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2666559449","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666559449?lang=en_us&edition=fundamental","pubTime":"2026-09-10 09:40","pubTimestamp":1789004400,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Optiscan rises after imaging more than 80 cases in ACL study** Shares of Australia's Optiscan ImagingOIL.AXrise as much as 10% to A$0.165, their biggest intraday pct gain since August 19** Shares hit their highest levels since August 27** The medical technology firmsaysit has imaged more than 80 cases in a study with Australian Clinical Labs  using its InForm digital pathology imaging device** Company says study uses InForm device for real-time, slide-free cellular imaging at point of contact, in real-world pathology environment** Optiscan stock up 60%, YTD","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nL4N452020:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","X2M.AU","OIL.AU","BK7084","ACL.AU","BK7124"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666115556","title":"Optiscan Imaging Says 84 Cases Imaged in Study Using Digital Pathology Imaging Device","url":"https://stock-news.laohu8.com/highlight/detail?id=2666115556","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666115556?lang=en_us&edition=fundamental","pubTime":"2026-09-10 08:56","pubTimestamp":1789001773,"startTime":"0","endTime":"0","summary":"Optiscan Imaging  said 84 cases were imaged in its digital pathology study with Australian Clinical Labs , using its InForm digital pathology imaging device, according to a Thursday Australian bourse filing.The device is providing real-time, slide-free cellular imaging at the point of contact. The cases imaged to date span a broad range of human tissue samples across multiple organs and systems as well as pathologies.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OIL.AU","BK7007","BK7124","ACL.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":11,"pageCount":1,"totalSize":41,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ACL.AU\",params:#limit:6,delay:true,,,undefined,":[]}}